This is supported by observations that increased HGF levels seen clinically in MM patients are associated with lower levels of serum markers of bone formation (bone-specific alkaline phosphatase and procollagen type 1 N-terminal propeptide) [18]. This evidence concerns the gene HGF and Miyoshi myopathy.